Recent Updates
Recently added Catalysts
MYGN Positive Sentiment

Myriad Genetics Earns 2023 Great Place to Work Certification™

Key Takeaway: Myriad Genetics has been awarded the 2023 Great Place to Work certification, with 86% of employees rating the company positively. This certification reflects Myriad's focus on fostering an inclusive and collaborative workplace. CEO Paul J. Diaz expressed gratitude to the staff for their contributions towards advancing the company's mission. The recognition reinforces Myriad's status as a desirable employer based on the experiences shared by its employees.
Price reaction · baseline $19.29 (2023-05-05 close) · clean, no other MYGN news in the window
day 0 close
-5%
day 1
-6.7%
day 3 · peak
-9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Achieved 'Great Place to Work' certification in 2023.
  • 86% of employees believe it is a great workplace, significantly higher than average.
  • Commitment to an open, collaborative, and inclusive work environment.
  • Recognition is based on employee feedback, highlighting strong workplace culture.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~41 mo
Minimal dilution risk
Lead asset
SKB264
Phase 2 · Solid Tumor

Full Press Release Details

SALT LAKE CITY, May 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has achieved the Great Place to Work® certification for 2023.
The certification is based solely on what current employees say about their experience working at Myriad. This year, 86% of Myriad employees said the company is a great place to work – 29 percentage points higher than a typical U.S. company.
“At Myriad Genetics we are committed to fostering an open, collaborative and inclusive work environment that supports all of our teammates,” said Paul J. Diaz, president and CEO, Myriad Genetics. “We are thrilled to be Great Place to Work certified and are grateful for our more than 2,600 Myriad teammates who work hard every day to fulfill our mission of advancing health and well-being for all.”
Great Place To Work is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation.
"Great Place To Work Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience," says Sarah Lewis-Kulin, the Vice President of Global Recognition at Great Place To Work. “By successfully earning this recognition, it is evident that Myriad Genetics stands out as one of the top companies to work for, providing a great workplace environment for its employees."
For more information about careers at Myriad, please visit: https://myriad.com/working-at-myriad/joining-the-myriad-team/.
About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Myriad and the Myriad logo are registered trademarks or trademarks of Myriad Genetics, Inc. All third-party marks—® and ™—are the property of their respective owners.
About Great Place to Work Certification™
Great Place To Work® Certification™ is the most definitive “employer-of-choice” recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience – specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place To Work-Certified.
About Great Place To Work®
As the global authority on workplace culture, Great Place To Work® brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform and For All™ Model helps companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified™ or receiving recognition on a coveted Best Workplaces™ List.
Media Contact: Investor Contact:
Glenn Farrell Matt Scalo
(385) 318-3718 (801) 584-3532
PR@myriad.com Matt.Scalo@myriad.com

Frequently Asked Questions

What is the 2023 certification achieved by Myriad Genetics?

Myriad Genetics received the Great Place to Work® certification for 2023.

What percentage of Myriad employees feel it's a great workplace?

86% of Myriad employees believe it is a great place to work.

How does Great Place to Work certify companies?

Certification is based solely on employee feedback about their workplace experience.

Who is the CEO of Myriad Genetics?

Paul J. Diaz is the president and CEO of Myriad Genetics.

What is the mission of Myriad Genetics?

Myriad Genetics aims to advance health and well-being for everyone.

Last updated: May 8, 2023